1-3 of 3
Rene Costello
Close
Sort by
Journal Articles

Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study

Clinical Trials & Observations
Sigrun Thorsteinsdottir, Sigrun H. Lund, Ebba K. Lindqvist, Marianna Thordardottir, Gunnar Sigurdsson, Rene Costello, Debra Burton, Hlif Steingrimsdottir, Vilmundur Gudnason, Gudny Eiriksdottir, Kristin Siggeirsdottir, Tamara B. Harris, Ola Landgren, Sigurdur Y. Kristinsson
Journal: Blood Advances
Blood Adv (2017) 1 (27): 2790–2798.
https://doi.org/10.1182/bloodadvances.2017010454
Published: 2017
Journal Articles

Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study

Clinical Trials & Observations
Marianna Thordardottir, Ebba K. Lindqvist, Sigrun H. Lund, Rene Costello, Debra Burton, Neha Korde, Sham Mailankody, Gudny Eiriksdottir, Lenore J. Launer, Vilmundur Gudnason, Tamara B. Harris, Ola Landgren, Sigurdur Y. Kristinsson
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2186–2192.
https://doi.org/10.1182/bloodadvances.2017007609
Published: 2017
Journal Articles

Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma

Clinical Trials & Observations
Sham Mailankody, Dickran Kazandjian, Neha Korde, Mark Roschewski, Elisabet Manasanch, Manisha Bhutani, Nishant Tageja, Mary Kwok, Yong Zhang, Adriana Zingone, Laurence Lamy, Rene Costello, Candis Morrison, Malin Hultcrantz, Austin Christofferson, Megan Washington, Martin Boateng, Seth M. Steinberg, Maryalice Stetler-Stevenson, William D. Figg, Elli Papaemmanuil, Wyndham H. Wilson, Jonathan J. Keats, Ola Landgren
Journal: Blood Advances
Blood Adv (2017) 1 (22): 1911–1918.
https://doi.org/10.1182/bloodadvances.2017005934
Published: 2017